Beacon Targeted Therapies is part of Hanson Wade and was invented in 2015. Hanson Wade gives people the clarity to see where opportunity lies. We work in highly specialized fields to provide unmatched depth and quality of content. We work in sectors where the quality of information is the difference between success and failure.
Hanson Wade organizes a large portfolio of highly respected meetings in targeted therapies including World ADC, CAR-TCR Summit, Gene Therapy and World Bispecific to name but a few.
Find out more about Hanson Wade